Safety and efficacy of remimazolam versus propofol during EUS: a multicenter randomized controlled study
Authors:
- 4 April 2024
- journal article
- research article
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 100 (2) , 183-191.e1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Remimazolam versus propofol for deep sedation/anaesthesia in upper gastrointestinal endoscopy in elderly patients: A multicenter, randomized controlled trialJournal of Clinical Pharmacy and Therapeutics, 2022
- Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairmentBritish Journal of Anaesthesia, 2021
- Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trialDigestive and Liver Disease, 2021
- Remimazolam for anaesthesia or sedationCurrent Opinion in Anaesthesiology, 2020
- A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopyGastrointestinal Endoscopy, 2018
- Remimazolam: Pharmacologic Considerations and Clinical Role in AnesthesiologyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2016
- Adverse events associated with EUS and EUS with FNAGastrointestinal Endoscopy, 2013
- Hemodynamic characteristics of midazolam, propofol, and dexmedetomidine in healthy volunteersJournal of Clinical Anesthesia, 2011
- Deep Sedation Occurs Frequently During Elective Endoscopy with Meperidine and MidazolamAmerican Journal of Gastroenterology, 2005
- PropofolAnesthesiology, 2005